The Efficacy of High-Dose Dexamethasone vs. Other Treatments for Newly Diagnosed Immune Thrombocytopenia: A Meta-Analysis

Схожие документы

• Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab as First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia
  по: Zhou, Hu, et al.
  Опубликовано: (2019)
• Clinical efficacy of high-dose dexamethasone with sequential prednisone maintenance therapy for newly diagnosed adult immune thrombocytopenia in a real-world setting
  по: Xu, Jin, et al.
  Опубликовано: (2021)
• Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
  по: Hassan Zafar, Mir Sadaqat, et al.
  Опубликовано: (2018)
• Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia
  по: Mashhadi, Mohammad Ali, et al.
  Опубликовано: (2012)
• The effect of single course high dose dexamethasone on CD28/CTLA-4 balance in the treatment of patients with newly diagnosed primary immune thrombocytopenia
  по: Guo, Xinhong, et al.
  Опубликовано: (2015)